EuroPCR 2023 | Intravascular Lithotripsy (IVL) Balloon in the Treatment of Underexpanded Stents

Calcified coronary plaque (CCP) is a challenge for interventional cardiology. Stent underexpansion (SU) commonly associated with CCP could predispose to stent thrombosis or restenosis. Currently, SU in severe CCP can be treated by rotational atherectomy, orbital atherectomy, balloon cutting/scoring, non-compliant high-pressure balloons, or intravascular lithotripsy (IVL).

The aim of this meta-analysis was to determine the success rate of IVL treatment of SU in CCP. 

The primary endpoint was success rate of the IVL strategy, defined as adequate expansion of underexpanded stents. 

The analysis included 13 studies pooling 354 patients. Mean patient age was 71 years old, and most subjects were male. Follow-up was 2.6 months. The strategy was successful in 88.7% of cases. The mean minimal stent area (MSA) was reported in 6 studies; the pre-IVL value was 3.4 mm2 and the post-IVL value was 6.9 mm2.

Read also: EuroPCR 2023 | TAVR in Patients with Bicuspid Aortic Valve Stenosis.

The average stenosis diameter was reported in 7 studies, with a pre-IVL value of 69.4% and post-IVL value of 14.6%. The intraprocedural complication rate was 1.6%. 

Conclusion

Plaque modification with SU due to CCP with the use of IVL has proven to be safe, with a high success rate and very low incidence of complications.

Dr. Andrés Rodríguez.
Member of the Editorial Board of SOLACI.org.

Original Title: Intravascular lithotripsy for the treatment of underexpanded stents: A meta-regression. 

Reference: Caminti et al. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an emerging concern: the late loss of structural...

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as the standard treatment in patients with acute...

iVAC2L: New Contribution to Ventricular Assist Devices in High Risk PCIs

The use of mechanical circulatory support (MCS) is on the rise, or increasingly necessary, seeing as high risk percutaneous coronary interventions (HR-PCIs) with severe...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Watchman FLX and Improvement Impact vs. 2.5

Left atrial appendage occlusion (LAAO) represents an effective alternative to oral anticoagulation (OAC) in patients with non-valvular atrial fibrillation at high risk of thromboembolic...

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an emerging concern: the late loss of structural...

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...